Screener
Dyne Therapeutics, Inc. DYN Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 23,682 | 24,029 |
| Right-of-use assets | 19,652 | 20,742 |
| Restricted cash and other assets | 15,589 | 15,600 |
| Total assets | $1,079,950 | $1,186,958 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | 10,781 | 8,082 |
| Accrued expenses and other current liabilities | 29,211 | 37,548 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s total assets?
- Dyne Therapeutics, Inc. (DYN) reported total assets of $1.08B in Q1 2026.
- How has Dyne Therapeutics, Inc.'s total assets changed year-over-year?
- Dyne Therapeutics, Inc.'s total assets increased by 49.8% year-over-year, from $721.07M to $1.08B.
- What is the long-term trend for Dyne Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s total assets has grown at a 27.4% compound annual growth rate (CAGR), from $353.33M to $1.19B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Dyne Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude